Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRM | CTRPv2 | pan-cancer | AAC | 0.39 | 0.002 |
mRNA | GDI1 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.002 |
mRNA | TBC1D3G | CTRPv2 | pan-cancer | AAC | -0.33 | 0.002 |
mRNA | GGA2 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.002 |
mRNA | ZCCHC8 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.002 |
mRNA | ANXA5 | CTRPv2 | pan-cancer | AAC | -0.54 | 0.002 |
mRNA | MGA | CTRPv2 | pan-cancer | AAC | 0.37 | 0.002 |
mRNA | SLC25A33 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.002 |
mRNA | C1orf64 | CTRPv2 | pan-cancer | AAC | -0.42 | 0.002 |
mRNA | TBC1D3 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.002 |